Delivery Order SPE2DP15D0003-1197

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Medimmune Biologics, Inc. for the provision of influenza virus vaccine. The contract has a value of $2,646.00 and was awarded on October 9, 2014, with a final completion date of July 25, 2022. The contract is a firm fixed-price type and does not have a set-aside designation. As the prime contractor, Medimmune Biologics, Inc. will be responsible for delivering the required influenza virus vaccine. This contract...

<p>This is a federal contract award from the Defense agency Medical Supply Chain to Medimmune Biologics, Inc. for influenza virus vaccines. The contract has a ceiling value of $170,730.00 and was awarded on November 19, 2015 with a completion date of December 21, 2015. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. As the prime contractor, Medimmune Biologics, Inc. will be responsible for delivering the requested influenza virus vaccines to the government.</p>

This federal contract award, with ID SPE2DP15D0003|1199, was issued by the Defense Logistics Agency (DLA) to Medimmune Biologics, Inc. The $95,527.50 firm-fixed-price delivery order is for the provision of influenza virus vaccines. The contract has an ultimate completion date of December 21, 2015. There is no set-aside designation for this award. Medimmune Biologics, Inc. is a for-profit organization, and this award indicates they have received other federal contract and grant awards. The DLA,...

This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to MedImmune LLC on September 12, 2013. The contract has a ceiling value of $5,625,000.00 and a period of performance through August 31, 2015. It was awarded under the Pandemic Influenza Preparedness and Response 2012-2016 master indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract does not have a set-aside designation. As a...

<p>This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Medimmune Biologics, Inc., a for-profit organization. The contract is a Firm Fixed Price contract with a potential value of $2,032.50 and a completion date of January 20, 2016. The contract does not have a set-aside designation. The award date was December 29, 2015, and the place of performance is NO POTOMAC, MD 20878, USA.</p>

This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to MedImmune LLC for $1,800,000.00. The contract is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle, which is used by ASPR to procure products and services related to pandemic preparedness. The contract has an ultimate completion date of October 31, 2018 and does...

This federal contract award is for the delivery of influenza virus vaccines to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DOD). The contract was awarded to Seqirus USA Inc., a global biotechnology company that specializes in the development and delivery of influenza vaccines. The contract is a Firm Fixed Price Delivery Order with a potential value of $17,728,962.81 and a completion date of November 16, 2020. This contract was not set aside...

This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Seqirus USA Inc. for the delivery of influenza virus vaccines. The contract has a ceiling value of $259,000.00 and a period of performance ending on November 30, 2015. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. This contract supports annual flu...

This is a firm-fixed-price delivery order awarded by the Veterans Integrated Service Network 6, a civilian agency within the Department of Veterans Affairs, to Seqirus USA Inc. for the delivery of Seqirus influenza vaccines. The contract has a ceiling value of $165,361.50 and a completion date of June 14, 2025. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Seqirus holds with the VA National Acquisition Center, valued at $69.1 million, and potentially other IDCs...

This is a $2,100,000.00 firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Medimmune LLC for the funding of CGMP influenza vaccine optimized master and working seed lot production. The contract is part of the Pandemic Influenza Preparedness and Response 2012-2016 contract vehicle. There is no set-aside designation for this award. The contract has an ultimate completion date of October 31, 2013.